Document is current
Any future updates will be listed below
-
Authors
Suzuki, Kenshi https://orcid.org/0000-0001-7132-5337
Min, Chang-Ki
Kim, Kihyun
Lee, Je-Jung
Shibayama, Hirohiko
Ko, Po-Shen
Huang, Shang-Yi
Li, Sin-Syue
Ding, Bifeng
Khurana, Monica
Iida, Shinsuke
-
Funding
Funding for this research was provided by:
Amgen
- License Information
-
More Information
Article History
Received: 9 April 2021
Revised: 29 July 2021
Accepted: 2 August 2021
First Online: 19 August 2021
Declarations
:
: <b>HS</b> has received honoraria from Takeda, Ono, Novartis, Celgene, Janssen, Chugai, Sanofi, AstraZeneca and Kyowa Kirin; research funding from Janssen, Ono, Celgene, Novartis, Sanofi, AstraZeneca, AbbVie, and Chugai; and scholarship endowment from Astellas, Teijin, Shionogi, Eisai, Sanofi, Taiho, and Nippon Shinyaku. <b>SI</b> received grants and personal fees from Ono; received grants and fees from Takeda, Janssen, Celgene, Sanofi, Bristol-Myers Squibb, and Daiichi Sankyo during the conduct of this study; received grants from Chugai, Kyowa Kirin, and AbbVie, outside the submitted work. <b>KS</b>, <b>C-KM</b>, <b>KK</b>, <b>J-JL</b>, <b>P-SK</b>, <b>S-YH</b>, <b>BD</b>, <b>MK</b>, and <b>S-SL</b> have nothing to report.
: The study protocol was approved by institutional review boards or independent ethics committees of all participating institutions. Authors and sponsor (Amgen, Inc.) participated in conception and design of the study, and analysis and interpretation of data.
: All patients provided written informed consent.
: All authors read the manuscript and provided consent for publication.
